ABSTRACT… Introduction: Atherosclerosis is intrinsically an inflammatory disease. Numerous studies has shown that elevated levels of C-reactive protein (CRP) are associated with increased cardiovascular risk. The objectives of this study was to determine the correlation of clinical outcome in terms of 30 day mortality with various level of C-reactive proteins among patients presenting with acute coronary syndrome Study Design: Descriptive. Setting: Department of Cardiology, Punjab Institute of Cardiology Lahore. Period: 06 months. Material and Methods: Total 250 patients presented in emergency department and diagnosed as cases of acute coronary syndrome base on history of chest pain, ECG and cardiac biochemical markers were included in the study. Management of ACS was continued while CRP levels of each patient were measured by latest Agglutination method. Results: Our study included 250 patients with acute coronary syndrome with a mean age of 52.90±10.34 years. Male patients were 220 (88%). Regarding the clinical presentation of patients, 20 (8%) had unstable angina, 95(38%) had NSTEMI and 135 (54%) had STEMI.CRP level were measured, 184(73.6%) patients had CRP levels < 22mg/L with mortality of 12 (6.5%) at 30 days and 66 (26.4%) patients had CRP levels >22mg/L with mortality of which 13(19.6%) at 30 days. The mean CRP level was 17.9±12.47, 18.08±15.73 and 22.38 + 17.92 for patients with unstable angina, NSTEMI and STEMI respectively. The stratification of data for effect modifiers showed that 60(24%) patients had diabetes, 138 (55.2%) patients had hypertension and 65(26%) patients were smokers. Conclusion: Patients having higher CRP levels had higher risk of 30 day mortality. Key words:C-reactive protein, Acute coronary syndrome. Article Citation: Maqbool A, Asghar N, Ahmad S. Acute coronary syndrome; Co-relation of C-reactive protein with clinical outcome of patients.
Introduction: Atherosclerosis is intrinsically an inflammatory disease. Numerousstudies has shown that elevated levels of C-reactive protein (CRP) are associated with increasedcardiovascular risk. The objectives of this study was to determine the correlation of clinicaloutcome in terms of 30 day mortality with various level of C-reactive proteins among patientspresenting with acute coronary syndrome Study Design: Descriptive. Setting: Department ofCardiology, Punjab Institute of Cardiology Lahore. Period: 06 months. Material and Methods:Total 250 patients presented in emergency department and diagnosed as cases of acutecoronary syndrome base on history of chest pain, ECG and cardiac biochemical markers wereincluded in the study. Management of ACS was continued while CRP levels of each patientwere measured by latest Agglutination method. Results: Our study included 250 patients withacute coronary syndrome with a mean age of 52.90±10.34 years. Male patients were 220(88%). Regarding the clinical presentation of patients, 20 (8%) had unstable angina, 95(38%)had NSTEMI and 135 (54%) had STEMI.CRP level were measured, 184(73.6%) patients hadCRP levels < 22mg/L with mortality of 12 (6.5%) at 30 days and 66 (26.4%) patients hadCRP levels >22mg/L with mortality of which 13(19.6%) at 30 days. The mean CRP level was17.9±12.47, 18.08±15.73 and 22.38 + 17.92 for patients with unstable angina, NSTEMI andSTEMI respectively. The stratification of data for effect modifiers showed that 60(24%) patientshad diabetes, 138 (55.2%) patients had hypertension and 65(26%) patients were smokers.Conclusion: Patients having higher CRP levels had higher risk of 30 day mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.